A new study by Tulane University has uncovered a previously unknown molecular pathway that could be instrumental to halting lung cancer in its tracks.
Nov 27, 2023
0
87
A study conducted at the University of Turku, Finland, shows that plixorafenib, a new drug developed for treating melanoma and lung cancer, may also stop the progression of cutaneous squamous cell carcinoma.
Nov 22, 2023
0
56
Using a routine chest X-ray image, an artificial intelligence (AI) tool can identify non-smokers who are at high risk for lung cancer, according to a study being presented next week at the annual meeting of the Radiological ...
Nov 22, 2023
0
0
A Yale-led analysis of the genomes of more than 1 million people has shed light on the underlying biology of cannabis use disorder and its links to psychiatric disorders, abuse of other substances such as tobacco, and possibly ...
Nov 21, 2023
0
49
For patients with advanced or metastatic non-small cell lung cancer (NSCLC) and limited performance status, an immune checkpoint inhibitor drug called durvalumab is safe and may benefit overall survival, according to a new ...
Nov 21, 2023
0
37
Lung cancer is the leading cause of cancer deaths in the U.S., claiming more lives than prostate cancer, breast cancer, and colorectal cancer combined. However, it can be a curable disease if detected early through screening, ...
Nov 20, 2023
0
0
A new familial lung cancer caused by an inherited mutation in EGFR has been described in a study published online Oct. 23 in the Journal of Clinical Oncology.
Nov 19, 2023
0
1
Screening for lung cancer can save lives, and there's an urgent need for more screening of people of color. That's one of the takeaways from the newly released "State of Lung Cancer" report from the American Lung Association.
Nov 17, 2023
0
0
Major retailers Bunnings and IKEA have announced this week they will discontinue selling engineered stone. While this might mean you have to rethink your plans for your new kitchen benchtops, it's a positive step that will ...
Nov 16, 2023
0
0
A new editorial paper titled "Obesity paradox and lung cancer, metformin-based therapeutic opportunity?" has been published in Oncotarget.
Nov 15, 2023
0
0
